• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过无醋酸盐生物滤过纠正血液透析患者的慢性代谢性酸中毒不会影响甲状旁腺功能。

Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function.

作者信息

de Précigout V, Combe C, Blanchetier V, Larroumet N, Pommereau A, Potaux L, Aparicio M

机构信息

Service de Néphrologie-Hémodialyse, Hôpital Pellegrin, Bordeaux, France.

出版信息

Nephrol Dial Transplant. 1995;10(6):821-4.

PMID:7566610
Abstract

In eight patients remaining acidotic after more than 1 year of bicarbonate haemodialysis, we studied the effect of correcting the chronic metabolic acidosis using acetate-free biofiltration for 4 months on the course of secondary hyperparathyroidism. An AN69 capillary membrane was employed with a bicarbonate infusion rate initially set at 1.8 l/h in all patients and then adjusted in each one to obtain a predialysis bicarbonate of > or = 23 mmol/l. Standard blood chemistry parameters were determined every 2 weeks. Measurements of PTH, calcifediol and calcitriol, as well as calcium-PTH curves were determined at the beginning and end of the study. While acetate-free biofiltration appears to be an adequate technique for the correction of chronic metabolic acidosis when bicarbonate dialysis fails, this study indicates that it does not influence secondary hyperparathyroidism in haemodialysed patients. The level of intact PTH did not vary significantly and the calcium-PTH curves at 0 and 4 months were superimposable with no significant differences in the set point and the slope of the curves.

摘要

在8例接受碳酸氢盐血液透析1年多后仍存在酸中毒的患者中,我们研究了采用无醋酸盐生物滤过4个月纠正慢性代谢性酸中毒对继发性甲状旁腺功能亢进病程的影响。所有患者均使用AN69毛细血管膜,初始碳酸氢盐输注速率设定为1.8 l/h,然后对每例患者进行调整以获得透析前碳酸氢盐≥23 mmol/l。每2周测定一次标准血液化学参数。在研究开始和结束时测定甲状旁腺激素(PTH)、骨化二醇和骨化三醇水平,以及钙-PTH曲线。虽然当碳酸氢盐透析失败时,无醋酸盐生物滤过似乎是纠正慢性代谢性酸中毒的一种合适技术,但本研究表明,它对血液透析患者的继发性甲状旁腺功能亢进没有影响。完整PTH水平无显著变化,0个月和4个月时的钙-PTH曲线可重叠,曲线的设定点和斜率无显著差异。

相似文献

1
Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function.通过无醋酸盐生物滤过纠正血液透析患者的慢性代谢性酸中毒不会影响甲状旁腺功能。
Nephrol Dial Transplant. 1995;10(6):821-4.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.代谢性酸中毒对慢性肾衰竭患者血清1,25(OH)₂D₃水平的影响
Miner Electrolyte Metab. 1995;21(6):398-402.
4
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.口服帕立骨化醇用于治疗血液透析或腹膜透析患者的继发性甲状旁腺功能亢进。
Am J Nephrol. 2008;28(1):97-106. doi: 10.1159/000109398. Epub 2007 Oct 3.
5
Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.静脉注射1,25(OH)₂D疗法可提高血液透析患者中完整甲状旁腺激素的分泌设定点。
Miner Electrolyte Metab. 1997;23(1):25-32.
6
RenaGel efficacy in severe secondary hyperparathyroidism.RenaGel对重度继发性甲状旁腺功能亢进的疗效。
Nefrologia. 2002;22(5):448-55.
7
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.酸中毒纠正对血液透析患者血浆甲状旁腺激素浓度、钙和磷的直接影响:一项前瞻性研究。
Nephron. 2001 Mar;87(3):257-62. doi: 10.1159/000045923.
8
Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure.慢性肾衰竭血液透析患者血浆瘦素浓度与代谢性酸中毒严重程度之间的相互关系。
Exp Clin Endocrinol Diabetes. 2001;109(7):370-3. doi: 10.1055/s-2001-17409.
9
Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.静脉注射骨化三醇后继发性甲状旁腺功能亢进的改善及钙调定点的降低。
Kidney Int Suppl. 1993 Jun;41:S125-30.
10
Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.在继发性甲状旁腺功能亢进的血液透析患者中进行的交叉试验中,22-氧杂骨化三醇和骨化三醇对甲状旁腺激素分泌及骨矿物质代谢的影响。
Ther Apher Dial. 2007 Jun;11(3):202-9. doi: 10.1111/j.1744-9987.2007.00422.x.